Hexagon Capital Partners’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.08K | Hold |
|
|||||
|
2024
Q4 | $2.08K | Hold |
|
|||||
|
2024
Q3 | $13K | Hold |
|
|||||
|
2024
Q2 | $12K | Hold |
|
|||||
|
2024
Q1 | $18.6K | Hold |
|
|||||
|
2023
Q4 | $16.6K | Hold |
|
|||||
|
2023
Q3 | $12K | Hold |
|
|||||
|
2023
Q2 | $9.84K | Buy |
|
|||||
|
2023
Q1 | $3.62K | Hold |
|
|||||
|
2022
Q4 | $5.58K | Hold |
|
|||||
|
2022
Q3 | $59K | Hold |
|
|||||
|
2022
Q2 | $30K | Hold |
|
|||||
|
2022
Q1 | $43K | Hold |
|
|||||
|
2021
Q4 | $36K | Hold |
|
|||||
|
2021
Q3 | $42K | Hold |
|
|||||
|
2021
Q2 | $51K | Hold |
|
|||||
|
2021
Q1 | $56K | Hold |
|
|||||
|
2020
Q4 | $51K | Hold |
|
|||||
|
2020
Q3 | $47K | Buy |
|